Jefferson Cty. Pharm. Ass’n v. Abbott Labs
JUSTICE O’CONNOR, with whom JUSTICE BRENNAN, JUSTICE REHNQUIST, and JUSTICE STEVENS join, dissenting.
The issue that confronts the Court is one of statutory construction: whether the Robinson-Patman Act covers purchases of commodities by state and local governments for resale in competition with private retailers. [ Footnote 2/1 ] The Court’s task, therefore, is to discern the intent of the 1936 Congress which enacted the Robinson-Patman Act. I do not agree with the majority that this issue can be resolved by reference to cases under the Sherman Act or other statutes, or by reliance on the broad remedial purposes of the antitrust laws generally. The 1936 Congress simply did not focus on this issue. The business and legal communities have assumed for the past four decades that such purchases are not covered. For these reasons, as explained more fully below, I respectfully dissent.
I
A
The majority relies extensively on the interpretation this Court has given to the term “person” under the Sherman Act and other statutes as a guide to whether the terms “person” and “purchasers,” as used in § 2 of the Clayton Act, 38 Stat. 730, as amended by the Robinson-Patman Act (Act), 49 Stat. 1526, 15 U.S.C. § 13, include state and local governmental entities. See ante at 460 U. S. 155 -156. In my view, such reliance is misplaced. The question of the Robinson-Patman Act’s treatment of governmental purchases requires an independent examination of the legislative history of that Act to ascertain